SavedAdd your journal

Journals / BEYOGLU EYE JOURNAL / 2017 / Cilt: 2 - Sayı: 1

An Argus II Case Report

İrfan PERENTE
Gürkan ERDOĞAN
Mühittin TAŞKAPILI
Pages
33–37
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Presently described is Argus II implantation in a patient with RP.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The Argus II Retinal Prosthesis System (Second Sight Medical Products, Inc., Sylmar, CA, USA) is the first US Food and Drug Administration-approved retinal implant.
📊
Key Findings & Data:It provides electrical stimulation of the retina and induces visual perception in individuals with low vision.
💡
Conclusion & Impact:Presently described is Argus II implantation in a patient with RP.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The Argus II Retinal Prosthesis System (Second Sight Medical Products, Inc., Sylmar, CA, USA) is the first US Food and Drug Administration-approved retinal implant. It provides electrical stimulation of the retina and induces visual perception in individuals with low vision. It is used in patients with severe disease, such as retinitis pigmentosa (RP). Presently described is Argus II implantation in a patient with RP.

🔖

Cite This Article

PERENTE, İ., ERDOĞAN, G., TAŞKAPILI, M. (2017). An Argus II Case Report. BEYOGLU EYE JOURNAL, Cilt: 2 - Sayı: 1, 33–37. https://ajindex.com/articles/147702

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Rizzo JF. Update on retinal prosthetic research: the Boston Retinal Implant Project. J Neuroophthalmol 2011;31:160-8
  2. Fujikado T, Kamei M, Sakaguchi H, Kanda H, Morimoto T, Ikuno Y, et al. Testing of semichronically implanted retinal prosthesis by suprachoroidal-transretinal stimulation in patients with reti nitis pigmentosa. Invest Ophthalmol Vis Sci 2011;52:4726-33
  3. Matthaei M, Zeitz O, Keserü M, Wagenfeld L, Hornig R, Post N, et al. Progress in the development of vision prostheses. Ophthalmologica 2011;225:187-92
  4. Stanga P, Jalil A, Tsamis E, Papayannis A, Dorn J, Greenberg R, et al. Argus II electronic epiretinal prosthesis in advanced dry AMD: Safety and feasibility study and preliminary functional results. 16th EURETINA Congress, Copenhagen; 8-11 September 2016. http://www.euretina.org/copenhagen2016/downloads/EURETINACopenhagen16_Final_Programme_Press.pdf (acces date:18 April 2017)
  5. Weiland JD, Cho AK, Humayun MS. Retinal prostheses: current clinical results and future needs. Ophthalmology 2011;118:2227-37
  6. Chuang AT, Margo CE, Greenberg PB. Retinal implants: a systematic review. Br J Ophthalmol 2014;98:852-6
  7. Humayun MS, Dorn JD, da Cruz L, Dagnelie G, Sahel JA, Stanga PE, et al; Argus II Study Group. Interim results from the international trial of Second Sight's visual prosthesis. Ophthalmology 2012;119:779-88
  8. Ho AC, Humayun MS, Dorn JD, da Cruz L, Dagnelie G, Handa J, et al; Argus II Study Group. Long-Term Results from an Epiretinal Prosthesis to Restore Sight to the Blind. Ophthalmology 2015;122:1547-54
  9. Health Policy Advisory Committee on Technology. Technology Brief Update. Argus II Retinal Prosthesis System. August 2016 10. Montezuma SR, Tang PH, van Kuijk FJ, Drayna P, Koozekanani DD. Implantation of the Argus II Retinal Prosthesis in an Eye With Short Axial Length. Ophthalmic Surg Lasers Imaging Retina 2016;47:369-71.